Unmet Needs in Chronic Fibrosing ILD With Progressive Phenotype

Remote care reduced readmissions and improved functional outcomes in COPD in a recent study.

On this episode of Managed Care Cast, a research scholar at the Marron Institute of Urban Management at New York University discusses the latest findings in the Health of the Air report, which was presented at the recent American Thoracic Society 2021 International Conference.

A new device was able to distinguish between mild and very severe chronic obstructive pulmonary disease (COPD).

Courtney Blair, MD, discusses how COVID-19 has impacted patients with allergies and other respiratory conditions.

Smoking prevalence is projected to decline by 2035, yet health consequences persist due to slower reductions among older adults.

Patients with progressive pulmonary fibrosis who received nerandomilast showed improved forced vital capacity from baseline at 52 weeks in the phase 3 FIBRONEER-ILD trial.